| __timestamp | BioMarin Pharmaceutical Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 751040000 | 64538000 |
| Thursday, January 1, 2015 | 889895000 | 71914000 |
| Friday, January 1, 2016 | 1116854000 | 108973000 |
| Sunday, January 1, 2017 | 1313646000 | 141102000 |
| Monday, January 1, 2018 | 1491212000 | 251453000 |
| Tuesday, January 1, 2019 | 1704048000 | 120282000 |
| Wednesday, January 1, 2020 | 1860455000 | 186419000 |
| Friday, January 1, 2021 | 1846275000 | 277133000 |
| Saturday, January 1, 2022 | 2096039000 | 196245000 |
| Sunday, January 1, 2023 | 2419226000 | 131314000 |
| Monday, January 1, 2024 | 2853915000 |
In pursuit of knowledge
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market position. Over the past decade, BioMarin Pharmaceutical Inc. and Ligand Pharmaceuticals Incorporated have showcased contrasting trajectories in their annual revenue growth.
BioMarin, a leader in developing therapies for rare genetic diseases, has seen its revenue soar by over 220% from 2014 to 2023. Starting at approximately $751 million in 2014, BioMarin's revenue reached a remarkable $2.42 billion by 2023. This consistent upward trend highlights BioMarin's robust pipeline and strategic market positioning.
Conversely, Ligand Pharmaceuticals, known for its innovative drug discovery platform, experienced a more volatile revenue pattern. Despite a significant 330% increase from 2014 to 2018, Ligand's revenue fluctuated, peaking at $277 million in 2021 before declining to $131 million in 2023. This volatility underscores the challenges and opportunities in the biotech sector.
Bristol-Myers Squibb Company or BioMarin Pharmaceutical Inc.: Who Leads in Yearly Revenue?
Alnylam Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Teva Pharmaceutical Industries Limited vs BioMarin Pharmaceutical Inc.: Annual Revenue Growth Compared
Revenue Showdown: Teva Pharmaceutical Industries Limited vs Ligand Pharmaceuticals Incorporated
Annual Revenue Comparison: Biogen Inc. vs BioMarin Pharmaceutical Inc.
Who Generates More Revenue? Bio-Techne Corporation or BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
BioMarin Pharmaceutical Inc. and Xencor, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Lantheus Holdings, Inc. or Ligand Pharmaceuticals Incorporated?
ADMA Biologics, Inc. vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics
Comparing Revenue Performance: PTC Therapeutics, Inc. or Ligand Pharmaceuticals Incorporated?
HUTCHMED (China) Limited vs Ligand Pharmaceuticals Incorporated: Annual Revenue Growth Compared